Ravetch JV - Search Results

1

Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.

La Fleur L, Botling J, He F, Pelicano C, Zhou C, He C, Palano G, Mezheyeuski A, Micke P, Ravetch JV, Karlsson MCI, Sarhan D. La Fleur L, et al. Among authors: ravetch jv. Cancer Res. 2021 Feb 15;81(4):956-967. doi: 10.1158/0008-5472.CAN-20-1885. Epub 2020 Dec 8. Cancer Res. 2021. PMID: 33293426

2

Disruption of cell-cell adhesion enhances antibody-dependent cellular cytotoxicity: implications for antibody-based therapeutics of cancer.

Green SK, Karlsson MC, Ravetch JV, Kerbel RS. Green SK, et al. Among authors: ravetch jv. Cancer Res. 2002 Dec 1;62(23):6891-900. Cancer Res. 2002. PMID: 12460904

3

Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone.

Karlsson MC, Guinamard R, Bolland S, Sankala M, Steinman RM, Ravetch JV. Karlsson MC, et al. Among authors: ravetch jv. J Exp Med. 2003 Jul 21;198(2):333-40. doi: 10.1084/jem.20030684. J Exp Med. 2003. PMID: 12874264 Free PMC article.

4

Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus.

Wermeling F, Chen Y, Pikkarainen T, Scheynius A, Winqvist O, Izui S, Ravetch JV, Tryggvason K, Karlsson MC. Wermeling F, et al. Among authors: ravetch jv. J Exp Med. 2007 Oct 1;204(10):2259-65. doi: 10.1084/jem.20070600. Epub 2007 Sep 24. J Exp Med. 2007. PMID: 17893199 Free PMC article.

5

FcgammaRIIB deficiency leads to autoimmunity and a defective response to apoptosis in Mrl-MpJ mice.

McGaha TL, Karlsson MC, Ravetch JV. McGaha TL, et al. Among authors: ravetch jv. J Immunol. 2008 Apr 15;180(8):5670-9. doi: 10.4049/jimmunol.180.8.5670. J Immunol. 2008. PMID: 18390752

6

Identification of a receptor required for the anti-inflammatory activity of IVIG.

Anthony RM, Wermeling F, Karlsson MC, Ravetch JV. Anthony RM, et al. Among authors: ravetch jv. Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19571-8. doi: 10.1073/pnas.0810163105. Epub 2008 Nov 26. Proc Natl Acad Sci U S A. 2008. PMID: 19036920 Free PMC article.

7

Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.

Mattsson J, Yrlid U, Stensson A, Schön K, Karlsson MC, Ravetch JV, Lycke NY. Mattsson J, et al. Among authors: ravetch jv. J Immunol. 2011 Oct 1;187(7):3641-52. doi: 10.4049/jimmunol.1101107. Epub 2011 Aug 31. J Immunol. 2011. PMID: 21880985

8

Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions.

DiLillo DJ, Ravetch JV. DiLillo DJ, et al. Among authors: ravetch jv. Cancer Immunol Res. 2015 Jul;3(7):704-13. doi: 10.1158/2326-6066.CIR-15-0120. Cancer Immunol Res. 2015. PMID: 26138698 Review.

9

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis.

Georgoudaki AM, Prokopec KE, Boura VF, Hellqvist E, Sohn S, Östling J, Dahan R, Harris RA, Rantalainen M, Klevebring D, Sund M, Brage SE, Fuxe J, Rolny C, Li F, Ravetch JV, Karlsson MC. Georgoudaki AM, et al. Among authors: ravetch jv. Cell Rep. 2016 May 31;15(9):2000-11. doi: 10.1016/j.celrep.2016.04.084. Epub 2016 May 19. Cell Rep. 2016. PMID: 27210762 Free article.

10

Immunotherapy and Hyperprogression: Unwanted Outcomes, Unclear Mechanism.

Knorr DA, Ravetch JV. Knorr DA, et al. Among authors: ravetch jv. Clin Cancer Res. 2019 Feb 1;25(3):904-906. doi: 10.1158/1078-0432.CCR-18-3144. Epub 2018 Nov 5. Clin Cancer Res. 2019. PMID: 30397179 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page